Third, PD-L1 Combined Positive Score (CPS) assessment on archival primary tumor tissue may not reflect dynamic changes or temporal heterogeneity in PD-L1 expression at metastatic sites, potentially reducing its predictive accuracy for immunochemotherapy response. This evidence concerns the gene CD274 and neoplasm.